Tumor necrosis factor alpha sensitizes low epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy.
Year: 2001
Type: article
Source: PubMed
Authors: M Hambek, C Solbach, H G Schnuerch, M Roller, M Stegmueller, A Sterner-Kock, J Kiefer, R Knecht
Institution: Goethe University Frankfurt
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2129700323
